Accordingly, targeting DDR damage proteins like Wee1 and modulating DRR signaling and the DSB repair pathway provided a fresh perspective into carcinogenesis and cancer treatment, notably in hematological malignancies where the dysfunctional DNA damage repair mechanism is highly involved. This evidence concerns the gene WEE1 and cancer.